These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
737 related articles for article (PubMed ID: 33439969)
21. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma. Zhang Y; Tang Y; Guo C; Li G Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043 [TBL] [Abstract][Full Text] [Related]
22. Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma. Deng Z; Wang J; Xu B; Jin Z; Wu G; Zeng J; Peng M; Guo Y; Wen Z Biomed Res Int; 2019; 2019():2408348. PubMed ID: 31828095 [TBL] [Abstract][Full Text] [Related]
23. Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment. Li Z; Wang R; Qiu C; Cao C; Zhang J; Ge J; Shi Y Front Immunol; 2022; 13():834606. PubMed ID: 35392073 [TBL] [Abstract][Full Text] [Related]
24. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Xu H; Xiong C; Chen Y; Zhang C; Bai D Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569 [TBL] [Abstract][Full Text] [Related]
25. High mRNA Expression of Cui Z; Xiao L; Chen F; Wang J; Lin H; Li D; Wu Z Dis Markers; 2021; 2021():9971799. PubMed ID: 34457090 [TBL] [Abstract][Full Text] [Related]
26. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma. Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941 [TBL] [Abstract][Full Text] [Related]
27. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer. Li C; Liu T; Liu Y; Zhang J; Zuo D J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771 [TBL] [Abstract][Full Text] [Related]
28. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma. Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618 [TBL] [Abstract][Full Text] [Related]
29. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis. Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236 [TBL] [Abstract][Full Text] [Related]
30. Identification of Biomarkers Related to Immune Cell Infiltration in Hepatocellular Carcinoma Using Gene Co-Expression Network. Zhou W; Chen Y; Luo R; Li Z; Jiang G; Ou X Pathol Oncol Res; 2021; 27():601693. PubMed ID: 34257558 [TBL] [Abstract][Full Text] [Related]
31. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model. Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737 [TBL] [Abstract][Full Text] [Related]
32. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma. Lu SX; Zhang CZ; Luo RZ; Wang CH; Liu LL; Fu J; Zhang L; Wang H; Xie D; Yun JP Cancer Lett; 2017 Aug; 402():71-80. PubMed ID: 28577975 [TBL] [Abstract][Full Text] [Related]
33. The relationship among Girdin DNA methylation, its high expression, and immune infiltration in hepatocellular carcinoma: Clues from in silico analysis. Zhang C; Ke Y; Lei X; Liu X; Li H; Shi R; Wang L Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33660763 [TBL] [Abstract][Full Text] [Related]
34. Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601 [TBL] [Abstract][Full Text] [Related]
35. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy. Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976 [TBL] [Abstract][Full Text] [Related]
36. Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC). Shen H; Wang Z; Ren S; Wang W; Duan L; Zhu D; Zhang C; Duan Y Int Immunopharmacol; 2020 Apr; 81():106222. PubMed ID: 32007795 [TBL] [Abstract][Full Text] [Related]
37. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer. Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J Gene; 2022 Mar; 813():146117. PubMed ID: 34902511 [TBL] [Abstract][Full Text] [Related]
38. Prognostic potential of PRPF3 in hepatocellular carcinoma. Liu Y; Yang Y; Luo Y; Wang J; Lu X; Yang Z; Yang J Aging (Albany NY); 2020 Jan; 12(1):912-930. PubMed ID: 31926109 [TBL] [Abstract][Full Text] [Related]
39. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776 [TBL] [Abstract][Full Text] [Related]
40. CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Luo JP; Wang J; Huang JH Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34405225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]